TAG Mail: July – December 2020 Cumulative Listing of Reports, Publications, Medication Safety TAG Mail – 17 Dec 2020 COVID-19 RESOURCES & ARTICLES OF INTEREST Please click this link for the cumulative listing of COVID-19 resources in past TAG Mails. AUSTRALIAN Australian Government Department of Health - Australian COVID-19 Vaccination policy - link - COVID-19 advice on managing the health risks from COVID-19 on international flights - link - Newmarch House COVID-19 Outbreak Independent Review - link - Testing of asymptomatic aged care workers – information for providers (updated) - link - Australia secures 20 million extra Astra Zeneca vaccines - link Australian Institute for Health and Welfare (AIHW) - Impacts of COVID-19 on Medicare Benefits Scheme & Pharmaceutical Benefits Scheme service use - link - Cancer screening and COVID-19 in Australia - link Australian Prescriber - COVID-19 vaccines – are we there yet? - link CEC - Hotel and airport information resources - link National COVID-19 Clinical Evidence Taskforce - New and Updated recommendations as at 10/12/2020 --New Recommendations: Combined metabolic cofactor supplementation (CMCS), Vitamin D analogues (formerly just calcifediol, now also includes cholecalciferol) -- Updated Recommendations: Interferon β-1a, Lopinavir-ritonavir, Convalescent plasma, Favipiravir, Ivermectin, Vitamin D analogues (calcifediol/cholecalciferol), Oestrogen-containing therapies, Respiratory management of the deteriorating patient NSW Health Critical Intelligence Unit – Evidence checks - Deployment and vaccination plan for COVID-19 - link - Aged care facilities and COVID-19 - link NPS MedicineWise Podcast: Episode 20: Medicines for COVID-19 – where did we land? - link INTERNATIONAL WHO - Evidence to recommendations for COVID-19 vaccines: a framework to inform the assessment of evidence and formulation of subsequent COVID-19 vaccine recommendations - link - Pandemic fatigue: reinvigorating the public to prevent COVID-19: policy framework for supporting pandemic prevention and management (updated) - link - Refugee and migrant health in the context of the COVID-19 pandemic: assessment tool for response at municipal level in the WHO European Region - link - Stop the COVID-19 pandemic from becoming an AMR (Antimicrobial resistance) catastrophe - link - COVID-19 vaccine introduction and deployment costing tool - link - ‘Science in 5’ webinar series: Episode 16 COVID-19 How vaccines work? - Manufacturing, safety and quality control of vaccines - link - Responsible media reporting on COVID-19 vaccines - link - A systematic approach to monitoring and analysing public health and social measures (PHSM) in the context of the COVID-19 pandemic: underlying methodology and application of the PHSM database and PHSM Severity Index - link Canada -Health Canada – MedEffect Notices -- Pfizer-BioNTech COVID-19 vaccine: recommendations for people with serious allergies - link -- Canadians warned not to buy COVID-19 vaccines sold online or from unauthorized sources - link - National Collaborating Centre for Methods and Tools -- Rapid Review Update 1: What risk factors are associated with COVID-19 outbreaks and mortality in long-term care facilities and what strategies mitigate risk? - link -- Rapid Review: What is the evidence for COVID-19 transmission in acute care settings? - link UK -Department of Health and Social Care -- REACT-1 study of coronavirus transmission: November 2020 final results - link -NHS England Specialist Pharmacy Service (SPS) -- Summary of COVID-19 medicines guidance: Endocrine system disorders, Skin disorders -- Pharmacy Institutional Readiness for Management of vaccine. Guidance for Chief Pharmacists- link -- Standard Operating Procedures for Pfizer-BioNTech vaccine: Preparation of vaccine syringes for administration at end user locations; Receiving and storing vaccine at PCN designated sites; Preparing vaccine at PCN designated sites; Disposing of damaged, unused or expired vaccine at PCN designated sites; Dealing with spillages and breakages of vaccine at PCN sites; Poster to support staff when handling Pfizer-BioNTech COVID-19 vaccine -- Medicines Optimisation Guidance: --- Pfizer-BioNTech COVID-19 Vaccine: Summary of guidance for Healthcare Professionals; Excipients information; Using the vaccine in patients with porphyria; Contraindications and cautions summary for the Vaccine --- Drug monitoring: factors to consider during Covid-19 - link --- Guidance on the management of drugs requiring monitoring during COVID-19 - link --- Access to medicines information resources by pharmacy teams during COVID-19 - link; by hospital pharmacy teams during COVID-19 - link -NHS -- Standard operating procedure: COVID-19 local vaccination services deployment in community settings - link -MHRA -- COVID-19 Therapeutic Alert: Azithromycin in the Management of COVID-19 (SARS-CoV-2) positive patients - link -- Confirmation of guidance to vaccination centres on managing allergic reactions following COVID-19 vaccination with the Pfizer/BioNTech vaccine - link -Public Health England -- COVID-19 vaccination programme webpage link. Updated training resources and guidance: --- COVID-19 vaccination training slide set --- COVID-19 vaccination e-learning programme --- Guidance for commissioners and providers of services for people who use drugs or alcohol - link -Royal College of Obstetricians & Gynaecologists -- Guidance for antenatal screening and ultrasound in pregnancy in the coronavirus (COVID-19) pandemic. Information for healthcare professionals - link -Royal College of Paediatrics and Child Health -- National guidance for the recovery of elective surgery in children - link Page | 2 USA -Centers for Disease Control and Prevention -- Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths - link -- The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine - United States - link -FDA -- FDA Takes Key Action in Fight against COVID-19 by Issuing EUA for First COVID-19 Vaccine - link -King Guide to Parenteral Admixtures -- COVID-19 Vaccine Product Information - link JOURNAL ARTICLES BMJ - Vaccinating the UK: how the covid vaccine was approved, and other questions answered - link - Influence of prior comorbidities and chronic medications use on the risk of COVID-19 in adults: a population-based cohort study in Tarragona, Spain - link - Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study - link - Rwanda’s secret weapon against covid-19: trust - link - Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis - link - Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study - link - Opinion: Harm reduction principles can help us restore trust in public health messaging on covid-19 - link - Letter: Shepherding preprints through a pandemic - link British Journal of Clinical Pharmacology - Review: Challenges of drug development during the COVID‐19 pandemic: Key considerations for clinical trial designs - link Bulletin of the World Health Organisation - Ensuring equitable access to COVID-19 vaccines - link Cell - Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19 - link Cochrane - A supplement on collaborating in response to COVID-19 - link - What is the accuracy of changes in white blood cell (WBC) count for diagnosing COVID‐19? - link - For pregnant and postpartum women, does targeted client communication improve maternal and neonatal health? - link Diabetes Care - Association between Achieving Inpatient Glycemic Control and Clinical Outcomes in Hospitalized Patients with COVID-19: A Multicenter, Retrospective Hospital-Based Analysis - link Emergency Medicine Australasia - Epidemiology and clinical features of emergency department patients with suspected COVID‐19: Insights from Australia's ‘second wave’ (COVED‐4) - link Emerging Infectious Diseases - COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020 - link European Heart Journal - Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease - link European Journal of Epidemiology Page | 3 - Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta- analysis, and public policy implications - link Euro Surveillance - Community use of face masks and similar barriers to prevent respiratory illness such as COVID-19: a rapid scoping review - link Gene Therapy - Gene editing and RNAi approaches for COVID-19 diagnostics and therapeutics - link Infection Control & Hospital Epidemiology - Change in Hospital Antibiotic Use and Acquisition of Multidrug Resistant Gram-Negative Organisms after the Onset of Coronavirus Disease 2019 - link JAMA - All-Cause Excess Mortality and COVID-19–Related Mortality among US Adults Aged 25-44 Years, March-July 2020 (Research Letter) - link - Readmission and Death after Initial Hospital Discharge Among Patients with COVID-19 in a Large Multihospital System (Research Letter) - link - Viewpoint: Behaviourally Informed Strategies for a National COVID-19 Vaccine Promotion Program - Viewpoint: Evaluating SARS-CoV-2 Vaccines after Emergency Use Authorization or Licensing of Initial Candidate